Brief: Onxeo Announces Publication Of Preclinical Study Results Comparing Efficacy And Toxicity Of Olaparib And AsiDNA

Valerio Therapeutics SA

13/11/2019 17:26

Nov 13 (Reuters) - ONXEO SA  C4X.PA :
    * ONXEO ANNOUNCES PUBLICATION OF PRECLINICAL STUDY RESULTS
COMPARING EFFICACY AND TOXICITY OF OLAPARIB AND ASIDNA™ IN
FRONTIERS IN ONCOLOGY
    * IN-VIVO MODELS SHOWED THAT ONLY ASIDNA™ COULD DELAY
RESISTANCE
TO CARBOPLATIN WITHOUT INCREASING ITS TOXICITY

Source text for Eikon:  ID:nBw3VTPyXa 
Further company coverage:  C4X.PA 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com;))